Oesterreich S - Search Results

1

Intratumor Heterogeneity Affects Gene Expression Profile Test Prognostic Risk Stratification in Early Breast Cancer.

Gyanchandani R, Lin Y, Lin HM, Cooper K, Normolle DP, Brufsky A, Fastuca M, Crosson W, Oesterreich S, Davidson NE, Bhargava R, Dabbs DJ, Lee AV. Gyanchandani R, et al. Among authors: oesterreich s. Clin Cancer Res. 2016 Nov 1;22(21):5362-5369. doi: 10.1158/1078-0432.CCR-15-2889. Epub 2016 May 16. Clin Cancer Res. 2016. PMID: 27185370 Free PMC article.

2

The small heat shock protein HSP27 is not an independent prognostic marker in axillary lymph node-negative breast cancer patients.

Oesterreich S, Hilsenbeck SG, Ciocca DR, Allred DC, Clark GM, Chamness GC, Osborne CK, Fuqua SA. Oesterreich S, et al. Clin Cancer Res. 1996 Jul;2(7):1199-206. Clin Cancer Res. 1996. PMID: 9816288

3

HET/SAF-B overexpression causes growth arrest and multinuclearity and is associated with aneuploidy in human breast cancer.

Townson SM, Sullivan T, Zhang Q, Clark GM, Osborne CK, Lee AV, Oesterreich S. Townson SM, et al. Among authors: oesterreich s. Clin Cancer Res. 2000 Sep;6(9):3788-96. Clin Cancer Res. 2000. PMID: 10999774

4

Inhibition of oestrogen receptor activity by the co-repressor HET/SAF-B is relieved by blockade of histone deacetylase activity.

Oesterreich S, Zhang QP, Lee AV. Oesterreich S, et al. Eur J Cancer. 2000 Sep;36 Suppl 4:S43-4. doi: 10.1016/s0959-8049(00)00221-5. Eur J Cancer. 2000. PMID: 11056314 No abstract available.

5

High rates of loss of heterozygosity on chromosome 19p13 in human breast cancer.

Oesterreich S, Allredl DC, Mohsin SK, Zhang Q, Wong H, Lee AV, Osborne CK, O'Connell P. Oesterreich S, et al. Br J Cancer. 2001 Feb;84(4):493-8. doi: 10.1054/bjoc.2000.1606. Br J Cancer. 2001. PMID: 11207044 Free PMC article.

6

Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.

Oesterreich S, Zhang P, Guler RL, Sun X, Curran EM, Welshons WV, Osborne CK, Lee AV. Oesterreich S, et al. Cancer Res. 2001 Aug 1;61(15):5771-7. Cancer Res. 2001. PMID: 11479214

7

Cross-talk among estrogen receptor, epidermal growth factor, and insulin-like growth factor signaling in breast cancer.

Lee AV, Cui X, Oesterreich S. Lee AV, et al. Among authors: oesterreich s. Clin Cancer Res. 2001 Dec;7(12 Suppl):4429s-4435s; discussion 4411s-4412s. Clin Cancer Res. 2001. PMID: 11916236 Review.

8

New mechanisms of signal transduction inhibitor action: receptor tyrosine kinase down-regulation and blockade of signal transactivation.

Lee AV, Schiff R, Cui X, Sachdev D, Yee D, Gilmore AP, Streuli CH, Oesterreich S, Hadsell DL. Lee AV, et al. Among authors: oesterreich s. Clin Cancer Res. 2003 Jan;9(1 Pt 2):516S-23S. Clin Cancer Res. 2003. PMID: 12538509 Review.

9

Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway: progesterone receptor as a potential indicator of growth factor activity in breast cancer.

Cui X, Zhang P, Deng W, Oesterreich S, Lu Y, Mills GB, Lee AV. Cui X, et al. Among authors: oesterreich s. Mol Endocrinol. 2003 Apr;17(4):575-88. doi: 10.1210/me.2002-0318. Epub 2003 Jan 2. Mol Endocrinol. 2003. PMID: 12554765

10

Estrogen-mediated down-regulation of E-cadherin in breast cancer cells.

Oesterreich S, Deng W, Jiang S, Cui X, Ivanova M, Schiff R, Kang K, Hadsell DL, Behrens J, Lee AV. Oesterreich S, et al. Cancer Res. 2003 Sep 1;63(17):5203-8. Cancer Res. 2003. PMID: 14500345

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

265 results

Search Page